The modification in measles vaccination age as a consequence of the earlier decline of transplacentally transferred antimeasles antibodies in Turkish infants.
The maternal antibodies are gradually decreased at 9 to 12 months in infants. We determined the elimination period of maternal measles antibodies in 34 infants whose mothers had had a history of natural measles previously. Seropositivity rates at sixth and nine months of age were found to be 61.8% and 3.4%, respectively. The very low passive antibody at nine months of age may suggest the measles vaccination could be carried out earlier than just before the critical age of antibody level.
Altintaş
D U
DU
Department of Pediatrics, Cukurova University, Medical Faculty, Balcalt Hospital, Adana, Turkey.
Evliyaoğlu
N
N
Kilinç
B
B
Sen'an
D I
DI
Güneşer
S
S
D000367:Age Factors; D000914:Antibodies, Viral / Q000032:analysis*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007115:Immunization Schedule; D007116:Immunization, Passive; D007223:Infant; D008431:Maternal-Fetal Exchange / Q000276:immunology*; D008457:Measles / Q000276:immunology / Q000517:prevention & control*; D008458:Measles Vaccine / Q000008:administration & dosage; D008459:Measles virus / Q000276:immunology*; D011247:Pregnancy; D014421:Turkey; D014611:Vaccination
D000914:Antibodies, Viral; D008458:Measles Vaccine